These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 1606593)
1. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study. Cirkel U; Ochs H; Schneider HP; Mettler L; Mayer-Eichberger D; Schindler AE; Bühler K; Winkler U; Zahradnik HP; Künzig HJ Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593 [TBL] [Abstract][Full Text] [Related]
2. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study. Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial. Serra GB; Panetta V; Colosimo M; Romanini C; Lafuenti GB; Garcea N; Votano S; Agatensi L Clin Ther; 1992; 14 Suppl A():57-73. PubMed ID: 1606594 [TBL] [Abstract][Full Text] [Related]
4. Influence on hormone levels, lipid metabolism and reversibility of endocrinological changes after leuprorelin acetate depot therapy. Bühler K; Winkler U; Schindler AE Clin Ther; 1992; 14 Suppl A():104-13. PubMed ID: 1606590 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
6. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638 [TBL] [Abstract][Full Text] [Related]
7. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549 [TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy. Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742 [TBL] [Abstract][Full Text] [Related]
11. Use of GnRH depot analogue in the treatment of uterine fibroids. Auber G; Ricci G; Barciulli F; Pregazzi R; D'Ancona RL; Toffoletti FG Acta Eur Fertil; 1990; 21(4):185-9. PubMed ID: 2150737 [TBL] [Abstract][Full Text] [Related]
12. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890 [TBL] [Abstract][Full Text] [Related]
13. [Primary endocrine therapy as pre- and perimenopausal metastatic breast carcinoma with leuprorelin acetate depot. German Leuprorelin Study Group]. Untch M Zentralbl Gynakol; 1998; 120(6):284-92. PubMed ID: 9659699 [TBL] [Abstract][Full Text] [Related]
14. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis]. Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083 [TBL] [Abstract][Full Text] [Related]
15. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732 [TBL] [Abstract][Full Text] [Related]
16. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog. Hutchins FL J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986 [TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532 [TBL] [Abstract][Full Text] [Related]
18. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause. Imai A; Sugiyama M; Furui T; Tamaya T J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of endometriosis with the GnRH agonist leuprorelin acetate depot (Enatone-Gyn monthly depot): a multicenter study]. Schindler AE; Bühler K; Gerhard I; Wiedemann R; Kimmig R; Schüssler B; Kranzfelder D; Mall-Häfeli M; Meinen K; Mancarella D Zentralbl Gynakol; 1994; 116(12):679-86. PubMed ID: 7846980 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]